Human Primary Immunodeficiency Diseases

Immunity

Volumn 27, Issue 6, 2007, Pages 835-845

  Fischer, Alain ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CELL DIFFERENTIATION; GENETICS; HUMAN; IMMUNE DEFICIENCY; LYMPHOCYTE ACTIVATION; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SOMATIC MUTATION;

CELL DIFFERENTIATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; NEUTROPHILS; RECOMBINATION, GENETIC; SIGNAL TRANSDUCTION;

EID: 37149022518     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2007.11.012     Document Type: Review

References (90)

1. Acosta-Rodriguez E.V., Rivino L., Geginat J., Jarrossay D., Gattorno M., Lanzavecchia A., Sallusto F., and Napolitani G. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8 (2007) 639-646
2. Ahnesorg P., Smith P., and Jackson S.P. XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 124 (2006) 301-313
3. Aiuti A., Slavin S., Aker M., Ficara F., Deola S., Mortellaro A., Morecki S., Andolfi G., Tabucchi A., Carlucci F., et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296 (2002) 2410-2413
4. Antonarakis S.E., and Beckmann J.S. Mendelian disorders deserve more attention. Nat. Rev. Genet. 7 (2006) 277-282
5. + medullary thymic epithelial cells. Nat. Immunol. 8 (2007) 351-358
6. Bassing C.H., and Alt F.W. The cellular response to general and programmed DNA double strand breaks. DNA Repair (Amst.) 3 (2004) 781-796
7. Bendelac A., Savage P.B., and Teyton L. The biology of NKT cells. Annu. Rev. Immunol. 25 (2007) 297-336
8. Bernard F., Picard C., Cormier-Daire V., Eidenschenk C., Pinto G., Bustamante J.C., Jouanguy E., Teillac-Hamel D., Colomb V., Funck-Brentano I., et al. A novel developmental and immunodeficiency syndrome associated with intrauterine growth retardation and a lack of natural killer cells. Pediatrics 113 (2004) 136-141
9. Bernasconi A., Marino R., Ribas A., Rossi J., Ciaccio M., Oleastro M., Ornani A., Paz R., Rivarola M.A., Zelazko M., and Belgorosky A. Characterization of immunodeficiency in a patient with growth hormone insensitivity secondary to a novel STAT5b gene mutation. Pediatrics 118 (2006) e1584-e1592
10. Berridge M.J., Bootman M.D., and Roderick H.L. Calcium signalling: dynamics, homeostasis and remodelling. Nat. Rev. Mol. Cell Biol. 4 (2003) 517-529
11. Bidere N., Su H.C., and Lenardo M.J. Genetic disorders of programmed cell death in the immune system. Annu. Rev. Immunol. 24 (2006) 321-352
12. Biron C.A., Byron K.S., and Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320 (1989) 1731-1735
13. Buck D., Malivert L., de Chasseval R., Barraud A., Fondaneche M.C., Sanal O., Plebani A., Stephan J.L., Hufnagel M., le Deist F., et al. Cernunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124 (2006) 287-299
14. Buckley R.H. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu. Rev. Immunol. 22 (2004) 625-655
15. Casanova J.L., and Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu. Rev. Immunol. 20 (2002) 581-620
16. Casrouge A., Zhang S.Y., Eidenschenk C., Jouanguy E., Puel A., Yang K., Alcais A., Picard C., Mahfoufi N., Nicolas N., et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314 (2006) 308-312
17. Cavadini P., Vermi W., Facchetti F., Fontana S., Nagafuchi S., Mazzolari E., Sediva A., Marrella V., Villa A., Fischer A., et al. AIRE deficiency in thymus of 2 patients with Omenn syndrome. J. Clin. Invest. 115 (2005) 728-732
18. Cavazzana-Calvo M., Hacein-Bey S., De Saint Basile G., Gross F., Yvon E., Nusbaum P., Selz F., Hue C., Certain S., Casanova J.L., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 288 (2000) 669-672
19. Cornéo B., Moshous D., Güngor T., Wulffraat N., Philippet P., Le Deist F., Fischer A., and de Villartay J.P. Identical mutations in RAG1 or RAG2 genes leading to defective V(D)J recombinase activity can cause either T-B- SCID or Omenn syndrome. Blood 97 (2001) 2772-2776
20. Crozat K., Hoebe K., Ugolini S., Hong N.A., Janssen E., Rutschmann S., Mudd S., Sovath S., Vivier E., and Beutler B. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J. Exp. Med. 204 (2007) 853-863
21. Curotto de Lafaille M.A., Muriglan S., Sunshine M.J., Lei Y., Kutchukhidze N., Furtado G.C., Wensky A.K., Olivares-Villagomez D., and Lafaille J.J. Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes. J. Exp. Med. 194 (2001) 1349-1359
22. De Villartay J.P., Fischer A., and Durandy A. The mechanisms of immune diversification and their disorders. Nat. Rev. Immunol. 3 (2003) 962-972
23. de Villartay J.P., Lim A., Al-Mousa H., Dupont S., Déchanet-Merville J., Caumau Gatbois E., Gougeon M.L., Abel L., Casanova J.L., Fischer A., and Le Deist F. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection. J. Clin. Invest. 115 (2005) 3291-3299
24. Durandy A., Taubenheim N., Peron S., and Fischer A. Pathophysiology of B-cell intrinsic immunoglobulin class switch recombination deficiencies. Adv. Immunol. 94C (2007) 275-306
25. Ehl S., Schwarz K., Enders A., Duffner U., Pannicke U., Kuhr J., Mascart F., Schmitt-Graeff A., Niemeyer C., and Fisch P. A variant of SCID with specific immune responses and predominance of gamma delta T cells. J. Clin. Invest. 115 (2005) 3140-3148
26. Eidenschenk C., Dunne J., Jouanguy E., Fourlinnie C., Gineau L., Bacq D., McMahon C., Smith O., Casanova J.L., Abel L., and Feighery C. A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8. Am. J. Hum. Genet. 78 (2006) 721-727
27. Eidenschenk C., Jouanguy E., Alcais A., Mention J.J., Pasquier B., Fleckenstein I.M., Puel A., Gineau L., Carel J.C., Vivier E., et al. Familial NK cell deficiency associated with impaired IL-2- and IL-15-dependent survival of lymphocytes. J. Immunol. 177 (2006) 8835-8843
28. Etzioni A., Eidenschenk C., Katz R., Beck R., Casanova J.L., and Pollack S. Fatal varicella associated with selective natural killer cell deficiency. J. Pediatr. 146 (2005) 423-425
29. Feske S., Muller J.M., Graf D., Kroczek R.A., Drager R., Niemeyer C., Baeuerle P.A., Peter H.H., and Schlesier M. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur. J. Immunol. 26 (1996) 2119-2126
30. Feske S., Giltnane J., Dolmetsch R., Staudt L.M., and Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat. Immunol. 2 (2001) 316-324
31. Feske S., Gwack Y., Prakriya M., Srikanth S., Puppel S.H., Tanasa B., Hogan P.G., Lewis R.S., Daly M., and Rao A. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441 (2006) 179-185
32. Fischer A. Human primary immunodeficiency diseases: a perspective. Nat. Immunol. 5 (2004) 23-30
33. Fischer A., and Notarangelo L.D. Combined immunodeficiencies. In: Stiehm E.R., Ochs H.D., and Winkelstein J.A. (Eds). Immunologic Disorders in Infants and Children. Fifth Edition. (2003), Elsevier Saunder, Philadelphia, PA 447-479
34. Fischer A., Le Deist F., Hacein-Bey-Abina S., Andre-Schmutz I., de Saint Basile G., de Villartay J.P., and Cavazzana-Calvo M. Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol. Rev. 203 (2005) 98-109
35. Fischer A., Latour S., and de Saint Basile G. Genetic defects affecting lymphocyte cytotoxicity. Curr. Opin. Immunol. 19 (2007) 348-353
36. Gao Y., Sun Y., Frank K.M., Dikkes P., Fujiwara Y., Seidl K.J., Sekiguchi J.M., Rathbun G.A., Swat W., Wang J., et al. A critical role for DNA end-joining proteins in both lymphogenesis and neurogenesis. Cell 95 (1998) 891-902
37. Geha R.S., Notarangelo L.D., Casanova J.L., Chapel H., Conley M.E., Fischer A., Hammarstrom L., Nonoyama S., Ochs H.D., Puck J.M., et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol. 120 (2007) 776-794
38. Gits J., van Leeuwen D., Carroll H.P., Touw I.P., and Ward A.C. Multiple pathways contribute to the hyperproliferative responses from truncated granulocyte colony-stimulating factor receptors. Leukemia 20 (2006) 2111-2118
39. Goodnow C.C. Multistep pathogenesis of autoimmune disease. Cell 130 (2007) 25-35
40. Grimbacher B., Holland S.M., and Puck J.M. Hyper-IgE syndromes. Immunol. Rev. 203 (2005) 244-250
41. Herve M., Isnardi I., Ng Y.S., Bussel J.B., Ochs H.D., Cunningham-Rundles C., and Meffre E. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance. J. Exp. Med. 204 (2007) 1583-1593
42. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., et al. STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357 (2007) 1608-1619
43. Holzelova E., Vonarbourg C., Stolzenberg M.C., Arkwright P.D., Selz F., Prieur A.M., Blanche S., Bartunkova J., Vilmer E., Fischer A., et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N. Engl. J. Med. 351 (2004) 1409-1418
44. Horwitz M.S., Duan Z., Korkmaz B., Lee H.H., Mealiffe M.E., and Salipante S.J. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 109 (2007) 1817-1824
45. Humblet-Baron S., Sather B., Anover S., Becker-Herman S., Kasprowicz D.J., Khim S., Nguyen T., Hudkins-Loya K., Alpers C.E., Ziegler S.F., et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J. Clin. Invest. 117 (2007) 407-418
46. Khiong K., Murakami M., Kitabayashi C., Ueda N., Sawa S., Sakamoto A., Kotzin B.L., Rozzo S.J., Ishihara K., Verella-Garcia M., et al. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J. Clin. Invest. 117 (2007) 1270-1281
47. Klein C., Grudzien M., Appaswamy G., Germeshausen M., Sandrock I., Schaffer A.A., Rathinam C., Boztug K., Schwinzer B., Rezaei N., et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 39 (2007) 86-92
48. Kollner I., Sodeik B., Schreek S., Heyn H., von Neuhoff N., Germeshausen M., Zeidler C., Kruger M., Schlegelberger B., Welte K., and Beger C. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 108 (2006) 493-500
49. Ku C.L., von Bernuth H., Picard C., Zhang S.Y., Chang H.H., Yang K., Chrabieh M., Issekutz A.C., Cunningham C.K., Gallin J., et al. Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J. Exp. Med. 204 (2007) 2407-2422
50. Lai C.H., Chun H.H., Nahas S.A., Mitui M., Gamo K.M., Du L., and Gatti R.A. Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc. Natl. Acad. Sci. USA 101 (2004) 15676-15681
51. Lau Y.L., Chan G.C., Ha S.Y., Hui Y.F., and Yuen K.Y. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin. Infect. Dis. 26 (1998) 226-227
52. Le Deist F., Hivroz C., Partiseti M., Thomas C., Buc H.A., Oleastro M., Belohradsky B., Choquet D., and Fischer A. A primary T-cell immunodeficiency associated with defective transmembrane calcium influx. Blood 85 (1995) 1053-1062
53. Leibundgut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., and Reis E.S.C. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8 (2007) 630-638
54. Leonard W.J. Cytokines and immunodeficiency diseases. Nat. Rev. Immunol. 1 (2001) 200-208
55. Levy O., Orange J.S., Hibberd P., Steinberg S., LaRussa P., Weinberg A., Wilson S.B., Shaulov A., Fleisher G., Geha R.S., et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J. Infect. Dis. 188 (2003) 948-953
56. Lilic D. New perspectives on the immunology of chronic mucocutaneous candidiasis. Curr. Opin. Infect. Dis. 15 (2002) 143-147
57. Lodoen M.B., and Lanier L.L. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18 (2006) 391-398
58. Ma C.S., Nichols K.E., and Tangye S.G. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 25 (2007) 337-379
59. Maianski N.A., Mul F.P., van Buul J.D., Roos D., and Kuijpers T.W. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood 99 (2002) 672-679
60. Maillard M.H., Cotta-de-Almeida V., Takeshima F., Nguyen D.D., Michetti P., Nagler C., Bhan A.K., and Snapper S.B. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J. Exp. Med. 204 (2007) 381-391
61. Marangoni F., Trifari S., Scaramuzza S., Panaroni C., Martino S., Notarangelo L.D., Baz Z., Metin A., Cattaneo F., Villa A., et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J. Exp. Med. 204 (2007) 369-380
62. Marrella V., Poliani P.L., Casati A., Rucci F., Frascoli L., Gougeon M.L., Lemercier B., Bosticardo M., Ravanini M., Battaglia M., et al. A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome. J. Clin. Invest. 117 (2007) 1260-1269
63. Medvedev A.E., Lentschat A., Kuhns D.B., Blanco J.C., Salkowski C., Zhang S., Arditi M., Gallin J.I., and Vogel S.N. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 198 (2003) 521-531
64. Milner J.D., Ward J.M., Keane-Myers A., and Paul W.E. Lymphopenic mice reconstituted with limited repertoire T cells develop severe, multiorgan, Th2-associated inflammatory disease. Proc. Natl. Acad. Sci. USA 104 (2007) 576-581
65. Minegishi Y., Saito M., Morio T., Watanabe K., Agematsu K., Tsuchiya S., Takada H., Hara T., Kawamura N., Ariga T., et al. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 25 (2006) 745-755
66. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448 (2007) 1058-1062
67. Nichols K.E., Hom J., Gong S.Y., Ganguly A., Ma C.S., Cannons J.L., Tangye S.G., Schwartzberg P.L., Koretzky G.A., and Stein P.L. Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11 (2005) 340-345
68. Notarangelo L.D., and Mazzolari E. Natural killer cell deficiencies and severe varicella infection. J. Pediatr. 148 (2006) 563-564
69. Notarangelo L.D., Gambineri E., and Badolato R. Immunodeficiencies with autoimmune consequences. Adv. Immunol. 89 (2006) 321-370
70. O'Driscoll M., Cerosaletti K.M., Girard P.M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol. Cell 8 (2001) 1175-1185
71. Ochs H.D., and Thrasher A.J. The Wiskott-Aldrich syndrome. J. Allergy Clin. Immunol. 117 (2006) 725-738
72. Orange J.S. Human natural killer cell deficiencies. Curr. Opin. Allergy Clin. Immunol. 6 (2006) 399-409
73. Partiseti M., Le Deist F., Hivroz C., Fischer A., Korn H., and Choquet D. The calcium current activated by T cell receptor and store depletion in human lymphocytes is absent in a primary immunodeficiency. J. Biol. Chem. 269 (1994) 32327-32335
74. Pasquier B., Yin L., Fondaneche M.C., Relouzat F., Bloch-Queyrat C., Lambert N., Fischer A., de Saint-Basile G., and Latour S. Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J. Exp. Med. 201 (2005) 695-701
75. Prakriya M., Feske S., Gwack Y., Srikanth S., Rao A., and Hogan P.G. Orai1 is an essential pore subunit of the CRAC channel. Nature 443 (2006) 230-233
76. Ramoz N., Rueda L.A., Bouadjar B., Montoya L.S., Orth G., and Favre M. Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis. Nat. Genet. 32 (2002) 579-581
77. Rigaud S., Fondaneche M.C., Lambert N., Pasquier B., Mateo V., Soulas P., Galicier L., Le Deist F., Rieux-Laucat F., Revy P., et al. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444 (2006) 110-114
78. Sanchez D.J., Gumperz J.E., and Ganem D. Regulation of CD1d expression and function by a herpesvirus infection. J. Clin. Invest. 115 (2005) 1369-1378
79. Skokowa J., Cario G., Uenalan M., Schambach A., Germeshausen M., Battmer K., Zeidler C., Lehmann U., Eder M., Baum C., et al. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat. Med. 12 (2006) 1191-1197
80. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13 (2007) 139-145
81. The International HapMap Consortium. A haplotype map of the human genome. Nature 437 (2006) 1299-1320
82. Vig M., Beck A., Billingsley J.M., Lis A., Parvez S., Peinelt C., Koomoa D.L., Soboloff J., Gill D.L., Fleig A., et al. CRACM1 multimers form the ion-selective pore of the CRAC channel. Curr. Biol. 16 (2006) 2073-2079
83. Vig M., Peinelt C., Beck A., Koomoa D.L., Rabah D., Koblan-Huberson M., Kraft S., Turner H., Fleig A., Penner R., and Kinet J.P. CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312 (2006) 1220-1223
84. Villa A., Sobacchi C., Notarangelo L.D., Bozzi F., Abinun M., Abrahamsen T.G., Arkwright P.D., Baniyash M., Brooks E.G., Conley M.E., et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood 97 (2001) 81-88
85. Vogt G., Vogt B., Chuzhanova N., Julenius K., Cooper D.N., and Casanova J.L. Gain-of-glycosylation mutations. Curr. Opin. Genet. Dev. 17 (2007) 245-251
86. Wada T., Toma T., Okamoto H., Kasahara Y., Koizumi S., Agematsu K., Kimura H., Shimada A., Hayashi Y., Kato M., and Yachie A. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency. Blood 106 (2005) 2099-2101
87. Watford W.T., and O'Shea J.J. Human tyk2 kinase deficiency: another primary immunodeficiency syndrome. Immunity 25 (2006) 695-697
88. Welch E.M., Barton E.R., Zhuo J., Tomizawa Y., Friesen W.J., Trifillis P., Paushkin S., Patel M., Trotta C.R., Hwang S., et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature 447 (2007) 87-91
89. Yeromin A.V., Zhang S.L., Jiang W., Yu Y., Safrina O., and Cahalan M.D. Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai. Nature 443 (2006) 226-229
90. Zhang S.Y., Jouanguy E., Ugolini S., Smahi A., Elain G., Romero P., Segal D., Sancho-Shimizu V., Lorenzo L., Puel A., et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317 (2007) 1522-1527